2m 2m 2m 2m 2m 2m 2m
CRESCENT BIOPHAR (CBIO)
NASDAQ
$19.37-$0.05 (-0.23%)
Price as of Sep 11, 2026 7:30 PM EDT- $292.5MMarket Cap
- 55.40%1-Year Change
- BiotechnologyIndustry
CRESCENT BIOPHAR (CBIO)
$19.37-$0.05 (-0.23%)
CBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $19.41 | ||
Change | -$0.05 (-0.26%) | ||
Open | $19.81 | ||
High | $20.35 | ||
Low | $19.11 | ||
Previous Close | $19.46 | ||
Volume | 264,448 | ||
30-Day Average Volume | 263,571 | ||
1-Week Change | -7.04% | ||
1-Month Change | 16.30% | ||
1-Year Change | 55.40% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 37.1M | ||
Total Assets | $182.8M | ||
Market Cap | $292.5M | ||
Enterprise Value | $120.9M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$24.8M | ||
Free Cash Flow | -$19.5M | ||
EBIT | -$24.8M | ||
EBITDA | -$24.8M | ||
Net Working Capital | $160.5M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -37 | ||
Price/Operating Cash Flow | -37 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 10/31/2023 | ||
Earnings & Revenue
Annual Dividend Yield